Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC

Clinical trial NCT07200154 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07200154
Sponsor: Peking University Cancer Hospital & Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Limited-stage Small-cell Lung Cancer Concurrent Chemoradiation Therapy

Start date: 2025-09-30
Primary completion: 2028-03-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.